IHC - P53 Tumor Suppressor Protein | Test | Sprint Diagnostic

No, fasting is not required for this test as it's performed on tissue samples, typically obtained through a biopsy or surgical procedure.

No specific preparation is required. The tissue sample is usually collected by a healthcare provider during a biopsy or surgical procedure.

This test is usually recommended when there is a suspicion of cancer, particularly in cases where the cancer is aggressive or resistant to treatment.

This test detects the presence or absence of the p53 protein. It helps to assess whether the p53 protein is functioning normally or is mutated, a common occurrence in many cancers.

The frequency of this test depends on your doctor's advice and is generally conducted during the diagnostic process or when monitoring the response to treatment.

The interpretation of the p53 IHC test is based on the detection of the p53 protein rather than a numerical value. The presence of normal p53 is a positive sign, while abnormal accumulation may suggest a mutation and a possible cancerous condition.

As the test is performed on tissue samples, the main precautions relate to the biopsy or surgical procedure used to obtain the sample.

p53 levels can be influenced by the presence of cancer. There are no known modifiable factors affecting p53 expression.

If your p53 IHC test results are abnormal, it's recommended to consult an oncologist. They can guide you on the implications of the results and the subsequent steps to take.

While p53 is primarily associated with cancer, its expression may also be affected by other conditions, such as liver disease. Therefore, the test result should be interpreted alongside other clinical and diagnostic information.

p53 is found in all cells of the body but its abnormal accumulation is most commonly associated with certain types of cancers.

There are no specific medication restrictions before this test. However, always inform your doctor about any medications you're taking before any biopsy or surgical procedure.

No, this test requires a tissue sample, usually obtained via a biopsy or surgical procedure. Therefore, it needs to be performed in a healthcare setting by a trained professional.

The p53 IHC test is highly specific, but it should be interpreted in conjunction with other diagnostic tests and clinical findings for a comprehensive diagnosis.

The p53 IHC test plays a vital role in understanding the nature and prognosis of various cancers. Your healthcare team will guide you through the interpretation of your test results, planning your treatment course and supporting you through your healthcare journey.